What is Haematologic Technologies?
Headquartered in Essex Junction, Vermont, Haematologic Technologies operates as a premier provider of research reagents, specialized blood collection tubes, and sophisticated protein biochemistry services. The company distinguishes itself through deep technical expertise in blood coagulation, offering a comprehensive suite of contract research and development solutions. Their service portfolio encompasses custom protein purification, protein modification, and rigorous assay development, alongside GMP-compliant release and stability testing. By maintaining a catalog of over 150 high-quality products—including antibodies, inhibitors, substrates, and deficient plasmas—the organization serves as a critical partner for IVD and point-of-care reagent developers, ensuring precision and reliability in complex biochemical workflows.
How much funding has Haematologic Technologies raised?
Haematologic Technologies has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Haematologic Technologies
PPP
Public-Private Partnership
What's next for Haematologic Technologies?
The infusion of capital from this late-stage financing round provides Haematologic Technologies with the necessary liquidity to scale its GMP-certified infrastructure and enhance its R&D throughput. As the company navigates its next phase of growth, strategic priorities will likely focus on expanding its custom IVD and POC reagent manufacturing capacity to meet increasing global demand. By leveraging its established reputation in protein biochemistry, the firm is poised to deepen its integration into the clinical diagnostic supply chain, potentially exploring new market segments for its proprietary blood coagulation technologies. This financial stability allows for sustained investment in talent acquisition and technological innovation, ensuring the company remains at the forefront of the specialized reagents industry.
See full Haematologic Technologies company page
